Published in J Cardiovasc Pharmacol on December 01, 1993
Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest (1998) 1.72
Effects of cigarette smoke on endothelial function of pulmonary arteries in the guinea pig. Respir Res (2009) 0.95
Changes in functional and histological distributions of nitric oxide synthase caused by chronic hypoxia in rat small pulmonary arteries. Br J Pharmacol (2003) 0.91
Endogenous nitric oxide and pulmonary circulation response to hypoxia in high-altitude adapted Tibetan sheep. Eur J Appl Physiol (2004) 0.79
Exogenous ghrelin improves blood flow distribution in pulmonary hypertension-assessed using synchrotron radiation microangiography. Pflugers Arch (2011) 0.77
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest (2001) 2.59
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J (2005) 1.98
Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest (1991) 1.91
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation (2005) 1.84
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest (2000) 1.80
Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood (2001) 1.51
Muscle strength and body composition in adult women with Marfan syndrome. Rheumatology (Oxford) (2007) 1.47
Diabetic control in 102 insulin-treated out-patients. Diabetologia (1980) 1.47
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med (1995) 1.46
Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schönlein purpura. Preliminary results of a prospective uncontrolled trial. Nephron (1995) 1.45
5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol (2000) 1.42
Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. EMBO J (1991) 1.40
Case 4-1993. Inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiothorac Vasc Anesth (1993) 1.39
Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res (1999) 1.37
Structural study of circulating thymic factor: a peptide isolated from pig serum. II. Amino acid sequence. J Biol Chem (1977) 1.34
Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J (2001) 1.26
Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci U S A (1986) 1.23
Molecular cloning and sequencing of the human erythrocyte 2,3-bisphosphoglycerate mutase cDNA: revised amino acid sequence. EMBO J (1986) 1.17
Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur Respir J (2005) 1.17
Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J (2001) 1.15
Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am J Physiol (1997) 1.14
Microscopic viscosity and rotational diffusion of proteins in a macromolecular environment. Biophys J (1999) 1.14
Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol (2000) 1.13
Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am J Respir Cell Mol Biol (2000) 1.12
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J (2006) 1.11
Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. Eur Respir J (2009) 1.11
Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Am J Physiol (1998) 1.10
Comparison of human bronchial muscle responses to histamine in vivo with histamine and isoproterenol agonists in vitro. Am Rev Respir Dis (1986) 1.07
Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest (1994) 1.07
Human erythrocyte band 3 polymorphism (band 3 Memphis): characterization of the structural modification (Lys 56----Glu) by protein chemistry methods. Blood (1991) 1.04
Cation- and peptide-binding properties of human centrin 2. FEBS Lett (2000) 1.04
High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Ann Intern Med (1994) 1.02
Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency. Effects of indomethacin. Chest (1993) 1.02
Hb Fontainebleau [alpha 21(B2)Ala----pro], a new silent mutant hemoglobin. Hemoglobin (1989) 1.01
Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats. Circ Res (2000) 1.01
Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. Am J Respir Crit Care Med (2000) 1.00
Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol (2000) 1.00
Histamine contraction of isolated human airway muscle preparations: role of prostaglandins. J Pharmacol Exp Ther (1986) 1.00
Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine. Am Rev Respir Dis (1987) 0.99
Pathobiology of pulmonary arterial hypertension. Eur Respir J (2002) 0.99
Hemoglobin variants and activity of the (K+Cl-) cotransport system in human erythrocytes. Blood (1992) 0.99
Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am J Physiol (1995) 0.96
Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. J Pharmacol Exp Ther (2001) 0.95
Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopenia. Haemostasis (1987) 0.95
Optimal handling of blood samples for routine measurement of lactate and pyruvate. Arch Pathol Lab Med (1994) 0.93
Haemodynamics and gas exchange before and after coil embolization of pulmonary arteriovenous malformations. Eur Respir J (1995) 0.92
Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol (2007) 0.92
Severe hypoxemia-associated intrapulmonary shunt in a patient with chronic liver disease: improvement after medical treatment. Am Rev Respir Dis (1992) 0.92
Structural study of hemoglobin Hazebrouck, beta 38(C4)Thr----Pro. A new abnormal hemoglobin with instability and low oxygen affinity. FEBS Lett (1984) 0.92
Beta-adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy. Am Heart J (1992) 0.92
Protein kinase C influences rat pulmonary vascular reactivity. Am Rev Respir Dis (1990) 0.91
Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents. J Pharmacol Exp Ther (1985) 0.91
L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol (1992) 0.90
Self-association of haemoglobin Olympia (alpha 2 beta 2 20 (B2) Val----Met). A human haemoglobin bearing a substitution at the surface of the molecule. J Mol Biol (1986) 0.90
The human alpha-globin gene. The protein products of the duplicated genes are identical. Eur J Biochem (1980) 0.89
Insulin injections enhance cholesterol gallstone incidence by changing the biliary cholesterol saturation index and apo A-I concentration in hamsters fed a lithogenic diet. J Hepatol (2001) 0.89
Hemoglobin Saint Mandé beta 102 (G4) asn replaced by tyr: a new low oxygen affinity variant. FEBS Lett (1981) 0.88
Human isolated bronchial muscle preparations from asthmatic patients: effects of indomethacin and contractile agonists. Prostaglandins (1989) 0.88
Hemoglobin J Iran alpha 2 beta 2 77 (EF1) his----Asp in a Russian-Armenian family. Hemoglobin (1986) 0.88
Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia. Am J Respir Crit Care Med (1998) 0.87
A new silent hemoglobin variant in a black family from French West Indies, hemoglobin Le Lamentin alpha 20 His replaced by Gln. FEBS Lett (1982) 0.87
Structural study of hemoglobin Knossos, beta 27 (B9) Ala leads to Ser. A new abnormal hemoglobin present as a silent beta-thalassemia. FEBS Lett (1982) 0.87
Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. Pharmacol Res Commun (1986) 0.86
Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injury. Am J Respir Crit Care Med (1997) 0.86
Isolation and characterization of the gene encoding the muscle-specific isozyme of human phosphoglycerate mutase. Gene (1990) 0.86
Time course of muscular blood metabolites during forearm rhythmic exercise in hypoxia. J Appl Physiol (1985) (1986) 0.85
Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Am J Physiol (1997) 0.85
Structure of the EF corner favors deamidation of asparaginyl residues in hemoglobin: the example of Hb La Roche-sur-Yon [beta 81 (EF5) Leu----His]. Biochim Biophys Acta (1992) 0.85
Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. Am J Cardiol (1992) 0.85
The surface-exposed, trypsin-accessible segments of apolipoprotein B in the low-density lipoprotein of human serum. Fractionation and characterisation of the liberated peptides. Eur J Biochem (1982) 0.84